QAM
BMY icon

QCI Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

QCI Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,117
Closed -$116K – 173
2020
Q1 		$116K Sell
2,117
-120
-5% -$7.33K 0.01% 155
2019
Q4 		$141K Sell
2,237
-1,028
-31% -$58.9K 0.01% 153
2019
Q3 		$166K Sell
3,265
-1,109
-25% -$52.1K 0.01% 148
2019
Q2 		$198K Sell
4,374
-1,688
-28% -$78.6K 0.02% 138
2019
Q1 		$289K Sell
6,062
-332,938
-98% -$16.6M 0.03% 110
2018
Q4 		$17.6M Sell
339,000
-614
-0.2% -$33K 1.93% 16
2018
Q3 		$21.1M Buy
339,614
+1,275
+0.4% +$75.7K 2% 8
2018
Q2 		$18.7M Buy
338,339
+86,095
+34% +$4.65M 1.88% 14
2018
Q1 		$16M Buy
252,244
+5,688
+2% +$366K 1.69% 25
2017
Q4 		$15.1M Buy
246,556
+6,691
+3% +$419K 1.55% 35
2017
Q3 		$15.3M Buy
239,865
+8,099
+3% +$473K 1.7% 24
2017
Q2 		$12.9M Buy
231,766
+14,110
+6% +$768K 1.56% 41
2017
Q1 		$11.8M Buy
217,656
+4,362
+2% +$239K 1.49% 43
2016
Q4 		$12.5M Buy
213,294
+5,606
+3% +$306K 1.66% 33
2016
Q3 		$11.2M Buy
207,688
+2,634
+1% +$169K 1.56% 40
2016
Q2 		$15.1M Buy
205,054
+3,632
+2% +$257K 2.13% 10
2016
Q1 		$12.9M Buy
201,422
+6,927
+4% +$437K 1.88% 22
2015
Q4 		$13.4M Buy
194,495
+3,876
+2% +$256K 2.07% 16
2015
Q3 		$11.3M Buy
190,619
+3,752
+2% +$238K 1.85% 20
2015
Q2 		$12.4M Buy
186,867
+3,662
+2% +$241K 1.93% 16
2015
Q1 		$11.8M Buy
183,205
+3,055
+2% +$191K 1.85% 20
2014
Q4 		$10.6M Buy
180,150
+172,056
+2,126% +$9.7M 1.65% 32
2014
Q3 		$414K Buy
8,094
+40
+0.5% +$2K 0.06% 70
2014
Q2 		$391K Hold
8,054
– – 0.06% 71
2014
Q1 		$418K Sell
8,054
-100
-1% -$5.32K 0.07% 69
2013
Q4 		$433K Buy
8,154
+1,000
+14% +$50.9K 0.07% 65
2013
Q3 		$331K Sell
7,154
-1,400
-16% -$61.5K 0.06% 72
2013
Q2 		$382K Buy
+8,554
New +$371K 0.07% 64

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

QCI Asset Management's BMY Position: Q2 2020 in Review

QCI Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 2,117 shares — an estimated $116K sold.

QCI Asset Management first reported a position in BMY in Q2 2013 and held it in 28 quarters. The position peaked at $21.1M in Q3 2018. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • QCI Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • QCI Asset Management sold 2,117 Bristol-Myers Squibb shares in Q2 2020, an estimated $116K.
  • QCI Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 28 quarters.
  • QCI Asset Management's Bristol-Myers Squibb position peaked at $21.1M in Q3 2018.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.